ZURICH/BERLIN, Feb 19 (Reuters) - The Swiss blue-chip SMI was seen opening 0.1 percent easier at 9,257 points on Tuesday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks:
The company intends to return to shareholders the $7.8 billion Hitachi is paying for its Power Grids unit unless ABB sees an opportunity to generate more value for shareholders by using the money differently, Chief Executive Ulrich Spiesshofer told Swiss television SRF.
Straumann’s annual sales increased at their fastest rate in 13 years, the dental implant maker said, helping the company meet profit forecasts. It saw growth in the low-teen-percentage range this year, with further profitability improvements
FDA grants priority review to Genentech’s polatuzumab vedotin in previously treated aggressive lymphoma; FDA grants priority review to Genentech’s personalised medicine entrectinib
* Basilea Pharmaceutica AG: FY total revenue increased 31% to CHF 133 million; year-end cash position of CHF 223 million; operating loss in 2018 CHF 24.1 million (2017: CHF 17.1 million)
* Thurgauer Kantonalbank: FY profit of CHF 134.2 million exceeds the previous year’s figure by 3.7 percent; increases the dividend on participation certificates by 5 cents to 2.80 francs per share; sees for 2019 lower business success than in 2018
* Comet Group said its board of directors nominated Patrick Jany as an independent member of the board.
CEMBRA MONEY BANK AG: DEUTSCHE BANK RAISES TARGET PRICE TO SFR 99 FROM SFR 97
Swiss trade balance 3.04 bln Sfr in Jan vs revised 1.96 bln in Dec; Swiss watch exports +0.2 pct in Jan y/y in nominal terms to 1.623 bln Sfr (Reporting by Zurich newsroom and Berlin Speed Desk)